Cargando…

Aβ42 as a Biomarker of Alzheimer’s Disease: Is Saliva a Viable Alternative to Cerebrospinal Fluid?

The identification of reliable biomarkers in biological fluids is paramount to optimizing the diagnosis of Alzheimer’s disease (AD). Measurement of Aβ42, t-tau, and p-tau in cerebrospinal fluid (CSF) is the most accepted method to support the diagnosis of AD. However, lumbar puncture represents an i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boschi, Silvia, Roveta, Fausto, Grassini, Alberto, Marcinnò, Andrea, Cermelli, Aurora, Ferrandes, Fabio, Rainero, Innocenzo, Rubino, Elisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775629/ https://www.ncbi.nlm.nih.gov/pubmed/36552188 http://dx.doi.org/10.3390/brainsci12121729

Ejemplares similares

Investigating p62 Concentrations in Cerebrospinal Fluid of Patients with Dementia: A Potential Autophagy Biomarker In Vivo?
por: Rubino, Elisa, et al.
Publicado: (2022)

Impact of COVID-19 on chronic migraine treated with erenumab: a case report
por: Grassini, Alberto, et al.
Publicado: (2021)

Polymorphisms of the Proinflammatory Cytokine Genes Modulate the Response to NSAIDs but Not to Triptans in Migraine Attacks
por: Rubino, Elisa, et al.
Publicado: (2022)

A Novel PSEN1 Variant Leading to Posterior Cortical Atrophy: A Case Report
por: Roveta, Fausto, et al.
Publicado: (2023)

Decreased resistin plasmatic concentrations in patients with Alzheimer's disease: A case-control study
por: Marcinnò, Andrea, et al.
Publicado: (2022)

Increased orexin A concentrations in cerebrospinal fluid of patients with behavioural variant frontotemporal dementia
por: Roveta, Fausto, et al.
Publicado: (2021)

Analysis of the DNA methylation pattern of the promoter region of calcitonin gene-related peptide 1 gene in patients with episodic migraine: An exploratory case-control study
por: Rubino, Elisa, et al.
Publicado: (2022)

Effects of COVID-19 on a migrainous patient treated with erenumab: A case report
por: Grassini, Alberto, et al.
Publicado: (2021)

Anxiety and depression in Alzheimer’s disease: a systematic review of pathogenetic mechanisms and relation to cognitive decline
por: Botto, Rossana, et al.
Publicado: (2022)

The Carers’ Needs Assessment for Dementia (CNA-D): a validation study in the Italian population
por: Zucca, Milena, et al.
Publicado: (2021)

Machine Learning Profiling of Alzheimer's Disease Patients Based on Current Cerebrospinal Fluid Markers and Iron Content in Biofluids
por: Ficiarà, Eleonora, et al.
Publicado: (2021)

O057. Altered plasma adipokines concentrations in chronic migraine
por: Rubino, Elisa, et al.
Publicado: (2015)

P055. Prevalence of migraine in subclinical hypothyroidism: a case-control study
por: Rainero, Innocenzo, et al.
Publicado: (2015)

Genetic variants in the NOTCH4 gene influence the clinical features of migraine
por: Rubino, Elisa, et al.
Publicado: (2013)

Distributions of Aβ42 and Aβ42/40 in the Cerebrospinal Fluid in View of the Probability Theory
por: Lewczuk, Piotr, et al.
Publicado: (2021)

Association between the G1246A polymorphism of the hypocretin receptor 2 gene and cluster headache: a meta-analysis
por: Rainero, Innocenzo, et al.
Publicado: (2007)

Saliva samples are a viable alternative to blood samples as a source of DNA for high throughput genotyping
por: Abraham, Jean E, et al.
Publicado: (2012)

Neuropsychological Correlates of Pre-Frailty in Neurocognitive Disorders: A Possible Role for Metacognitive Dysfunction and Mood Changes
por: Amanzio, Martina, et al.
Publicado: (2017)

Metabolism and headache
por: Rainero, Innocenzo
Publicado: (2015)

A blood-based signature of cerebrospinal fluid Aβ(1–42) status
por: Goudey, Benjamin, et al.
Publicado: (2019)

Cerebrospinal fluid amyloid-β 2-42 is decreased in Alzheimer’s, but not in frontotemporal dementia
por: Bibl, Mirko, et al.
Publicado: (2012)

Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations
por: Lautner, Ronald, et al.
Publicado: (2017)

Cerebrospinal Fluid Aβ(42/40) Corresponds Better than Aβ(42) to Amyloid PET in Alzheimer’s Disease
por: Lewczuk, Piotr, et al.
Publicado: (2016)

Evidence for an association between migraine and the hypocretin receptor 1 gene
por: Rainero, Innocenzo, et al.
Publicado: (2011)

O056. Migraine as presenting symptom of SLC20A2gene mutations
por: Rubino, Elisa, et al.
Publicado: (2015)

Low cerebrospinal fluid Amyloid-βeta 1–42 in patients with tuberculous meningitis
por: Stroffolini, Giacomo, et al.
Publicado: (2021)

Cerebrospinal fluid ratios with Aβ(42) predict preclinical brain β-amyloid accumulation
por: Racine, Annie M., et al.
Publicado: (2015)

The nonlinear relationship between cerebrospinal fluid Aβ(42) and tau in preclinical Alzheimer’s disease
por: de Leon, Mony J., et al.
Publicado: (2018)

Autocatalytic amplification of Alzheimer-associated Aβ42 peptide aggregation in human cerebrospinal fluid
por: Frankel, Rebecca, et al.
Publicado: (2019)

Genes and primary headaches: discovering new potential therapeutic targets
por: Rainero, Innocenzo, et al.
Publicado: (2013)

Investigating the Effects of COVID-19 Quarantine in Migraine: An Observational Cross-Sectional Study From the Italian National Headache Registry (RICe)
por: Delussi, Marianna, et al.
Publicado: (2020)

Soluble HLA measurement in saliva and cerebrospinal fluid in Caucasian patients with multiple sclerosis: a preliminary study
por: Adamashvili, Irena, et al.
Publicado: (2005)

The Relationship between Different Assays for Detection and Quantification of Amyloid Beta 42 in Human Cerebrospinal Fluid
por: Ellis, Teresa A., et al.
Publicado: (2012)

Prediction of P-tau/Aβ42 in the cerebrospinal fluid with blood microRNAs in Alzheimer’s disease
por: Jia, Longfei, et al.
Publicado: (2021)

Lactoferrin in cerebrospinal fluid and saliva is not a diagnostic biomarker for Alzheimer's disease in a mixed memory clinic population
por: Gleerup, Helena Sophia, et al.
Publicado: (2021)

Magnetic Nanoparticles in the Central Nervous System: Targeting Principles, Applications and Safety Issues
por: D’Agata, Federico, et al.
Publicado: (2017)

Migraine during COVID-19: Data from Second Wave Pandemic in an Italian Cohort
por: Gentile, Eleonora, et al.
Publicado: (2021)

Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease Features
por: Goldman, Jennifer G., et al.
Publicado: (2017)

Cerebrospinal Fluid Aβ40 Improves the Interpretation of Aβ42 Concentration for Diagnosing Alzheimer’s Disease
por: Dorey, Aline, et al.
Publicado: (2015)

Lower Cerebrospinal Fluid Amyloid-β(42) Predicts Sooner Time to Antipsychotic Use in Alzheimer’s Disease
por: Cahan, Joshua G., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_glql4cj0s2ggpesv8i161valu9